CAD 0.13
(30.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -221.98 Thousand CAD | -4.84% |
2022 | -211.73 Thousand CAD | -249.46% |
2021 | -60.58 Thousand CAD | -245.24% |
2020 | -17.55 Thousand CAD | 31.98% |
2019 | -25.8 Thousand CAD | 13.36% |
2018 | -29.77 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -24.64 Thousand CAD | 60.43% |
2024 Q1 | -62.29 Thousand CAD | 2.21% |
2024 Q3 | -53.03 Thousand CAD | -115.19% |
2023 FY | -221.98 Thousand CAD | -4.84% |
2023 Q4 | -63.7 Thousand CAD | 16.84% |
2023 Q2 | -24.65 Thousand CAD | 56.77% |
2023 Q1 | -57.02 Thousand CAD | 28.43% |
2023 Q3 | -76.6 Thousand CAD | -210.7% |
2022 Q4 | -79.67 Thousand CAD | -199.48% |
2022 Q3 | -26.6 Thousand CAD | 55.41% |
2022 Q2 | -59.66 Thousand CAD | -5.53% |
2022 Q1 | -56.53 Thousand CAD | -521.77% |
2022 FY | -211.73 Thousand CAD | -249.46% |
2021 Q2 | -14.36 Thousand CAD | 0.0% |
2021 FY | -60.58 Thousand CAD | -245.24% |
2021 Q4 | -9093.00 CAD | 8.39% |
2021 Q3 | -9926.00 CAD | 30.89% |
2020 FY | -17.55 Thousand CAD | 31.98% |
2019 FY | -25.8 Thousand CAD | 13.36% |
2018 FY | -29.77 Thousand CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Biosenta Inc. | -6.29 Million CAD | 96.476% |